(Q39404483)

11 September 2017

title

Bispecific antibody complex pre-targeted delivery of polymer-drug conjugates for cancer therapy (English)

1 reference

11 September 2017

Keyur S Gada

1

1 reference

11 September 2017

Vishwesh Patil

2

1 reference

11 September 2017

Rajiv Panwar

3

1 reference

11 September 2017

Arash Hatefi

4

1 reference

11 September 2017

Ban-An Khaw

5

1 reference

11 September 2017

publication date

1 February 2012

1 reference

Drug delivery and translational research

11 September 2017

published in

1 reference

11 September 2017

volume

2

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

65-76

1 reference

https://scigraph.springernature.com/pub.10.1007/s13346-011-0055-x

11 September 2017

exact match

0 references

cites work

Timeline: Chemotherapy and the war on cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Poly(L-glutamic acid)--anticancer drug conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

In vivo targeting of acute myocardial infarction with negative-charge, polymer-modified antimyosin antibody: use of different cross-linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Immunoconjugates, drug-armed antibodies to fight against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Pretargeted gamma imaging of murine metastatic melanoma lung lesions with bispecific antibody and radiolabeled polymer drug conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Selection and characterization of HER2/neu-binding affibody ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0055-X

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

21 January 2018

1 reference

12 December 2020

Chemically optimized antimyosin Fab conjugates with chelating polymers: importance of the nature of the protein-polymer single site covalent bond for biodistribution and infarction localization

1 reference

12 December 2020

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

1 reference

12 December 2020

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

1 reference

12 December 2020

Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitro

1 reference

12 December 2020

Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress

1 reference

12 December 2020

Conjugation of camptothecins to poly-(L-glutamic acid)

1 reference

12 December 2020

Bispecific enzyme-linked signal-enhanced immunoassay with subattomole sensitivity

1 reference

12 December 2020

Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

1 reference

12 December 2020

Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate

1 reference

12 December 2020

Antibody–drug conjugates for cancer: poised to deliver?

1 reference

12 December 2020

Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent

1 reference

12 December 2020

The cardiotoxicity of anticancer agents.

1 reference

12 December 2020

Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers

1 reference

12 December 2020

Adriamycin cardiomyopathy: pathophysiology and prevention

1 reference

12 December 2020

Antibody engineering for the development of therapeutic antibodies

1 reference

12 December 2020

10.1007/S13346-011-0055-X

Identifiers

DOI

1 reference

11 September 2017

1 reference